Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists

Details for Australian Patent Application No. 2004257636 (hide)

Owner Neurocrine Biosciences, Inc.

Inventors Huang, Charles Q.; Rueter, Jaimie K.; Chen, Yongsheng; Regan, Collin; Zhu, Yun-Fei; Guo, Zhiqiang

Agent Davies Collison Cave

Pub. Number AU-B-2004257636

PCT Pub. Number WO2005/007164

Priority 60/485,436 07.07.03 US

Filing date 6 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 6 January 2011

International Classifications

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 5/02 (2006.01) Drugs for disorders of the endocrine system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/007164 Priority application(s): WO2005/007164

6 January 2011 Application Accepted

  Published as AU-B-2004257636

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257639-Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists

2004257632-Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections